Translational dysfunction based therapeutics Grant US-10472677-B2 United States of America 12 Nov 2019
Translational dysfunction based therapeutics Grant US-8497292-B2 United States of America 30 Jul 2013
Nucleoside derivatives for treatment of Caliciviridae infections, including Norovirus… Grant US-8415321-B2 United States of America 09 Apr 2013
TREATMENT OF DISEASES CAUSED BY VIRAL INFECTION Application US-20110033418-A1 United States of America 10 Feb 2011
Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and… Application US-7622605-B2 United States of America 24 Nov 2009
NUCLEOSIDE DERIVATIVES FOR TREATMENT OF CALICIVIRIDAE INFECTIONS, INCLUDING NOROVIRUS… Application US-20090280084-A1 United States of America 12 Nov 2009
TRANSLATIONAL DYSFUNCTION BASED THERAPEUTICS Application WO-2007123579-A2 World Intellectual Property Organisation (WIPO) 01 Nov 2007
Inhibitors of Hepatitis C virus RNA-dependent RNA polymerase, and compositions and… Application US-7151105-B2 United States of America 19 Dec 2006
Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and… Application US-7148226-B2 United States of America 12 Dec 2006
MUTAGENESIS METHODS USING RIBAVIRIN AND/OR RNA REPLICASES Application WO-2004039995-A1 World Intellectual Property Organisation (WIPO) 13 May 2004